Article http://dx.doi.org/10.26855/ijcemr.2024.01.032

Research Progress on the Mechanism of Kidney Injury Associated with Hyperuricemia


Jianchun Chen, Xiaoying Yang, Caizhong Zhang, Wanping Lv*

Chengdu Rheumatology Hospital, Chengdu, Sichuan, China.

*Corresponding author: Wanping Lv

Published: March 12,2024


Hyperuricemia (HUA) has become one of the global public health problems, and the mechanisms of renal injury caused by it have received increasing attention. This review focuses on the main mechanisms of hyperuricemia-associated renal injury, including the effects of three aspects: monosodium urate (MSU) crystal deposition, activated NLRP3 inflammasome, and mito-chondrial dysfunction. We explored in detail how MSU crystals lead to kidney injury by inducing oxidative stress, inflammatory responses, and apoptosis. Second, we found that the activation of NLRP3 inflammatory vesicles plays a key role in hyperuricemia-induced renal injury by triggering a strong inflammatory response and further destroying renal tissues. Finally, we also discussed the importance of mitochondrial dysfunction in hyperuricemia-induced kidney injury, noting that mitochondrial dysfunction may exacerbate kidney injury by affecting cellular energy metabolism and modulating cell death pathways. Through a comprehensive understanding of these mechanisms, we hope to provide new ideas for the prevention and treatment of hyperuricemia-associated kidney disease.


[1] Zhang W. Uric acid en route to gout [M]. Elsevier. 2023: 209-275.

[2] Ko J, Kang H, Kim D, et al. Uric acid induced the phenotype transition of vascular endothelial cells via induction of oxidative stress and glycocalyx shedding [J]. The FASEB Journal, 2019, 33(12): 13334-13345.

[3] Guan H, Zheng Y, Zhou X, et al. Efficacy of different urinary uric acid indicators in patients with chronic kidney disease [J]. BMC Nephrology, 2020, 21(1).

[4] Tsao H-M, Lai T-S, Chang Y-C, et al. Serum Urate and Risk of Chronic Kidney Disease [J]. Mayo Clinic Proceedings, 2023, 98(4): 513-521.

[5] Chen C, Lü J-M, Yao Q. Hyperuricemia-Related Diseases and Xanthine Oxidoreductase (XOR) Inhibitors: An Overview[J]. Medical Science Monitor, 2016, 22: 2501-2512.

[6] Mandal A K, Mount D B. The Molecular Physiology of Uric Acid Homeostasis [J]. Annual Review of Physiology, 2015, 77(1): 323-345.

[7] Keenan R T. The biology of urate [J]. Seminars in Arthritis and Rheumatism, 2020, 50(3): S2-S10.

[8] Mei Y, Dong B, Geng Z, et al. Excess Uric Acid Induces Gouty Nephropathy Through Crystal Formation: A Review of Recent Insights [J]. Frontiers in Endocrinology, 2022, 13.

[9] He Y, Zeng M Y, Yang D, et al. NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux [J]. Nature, 2016, 530(7590): 354-357.

[10] Fu J, Wu H. Structural Mechanisms of NLRP3 Inflammasome Assembly and Activation [J]. Annual Review of Immunology, 2023, 41(1): 301-316.

[11] Ai G, Huang R, Xie J, et al. Hypouricemic and nephroprotective effects of palmatine from Cortex Phellodendri Amurensis: A uric acid modulator targeting Keap1-Nrf2/NLRP3 axis [J]. Journal of Ethnopharmacology, 2023, 301: 115775.

[12] Ma C, Yang X, Lv Q, et al. Soluble uric acid induces inflammation via TLR4/NLRP3 pathway in intestinal epithelial cells [J]. Iranian Journal of Basic Medical Sciences, 2020.

[13] Jiang D, Fu C, Xiao J, et al. SGK1 Attenuates Oxidative Stress-Induced Renal Tubular Epithelial Cell Injury by Regulating Mito-chondrial Function [J]. Oxidative Medicine and Cellular Longevity, 2019: 1-12.

[14] Sánchez-Lozada L G, Lanaspa M A, Cristóbal-García M, et al. Uric Acid-Induced Endothelial Dysfunction Is Associated with Mitochondrial Alterations and Decreased Intracellular ATP Concentrations [J]. Nephron Experimental Nephrology, 2012, 121(3-4): e71-e78.

How to cite this paper

Research Progress on the Mechanism of Kidney Injury Associated with Hyperuricemia

How to cite this paper: Jianchun Chen, Xiaoying Yang, Caizhong Zhang, Wanping Lv. (2024) Research Progress on the Mechanism of Kidney Injury Associated with HyperuricemiaInternational Journal of Clinical and Experimental Medicine Research8(1), 187-190.

DOI: http://dx.doi.org/10.26855/ijcemr.2024.01.032